Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Medical and Diagnostic Laboratories
Oncoparse runs a Medical and Diagnostic Laboratories operation from Melbourne. Privately held, at oncoparse.com. It holds one address on record, all in Australia. It employs 4 people, on the record. One Australian registration (ABN) is a confirmed match. The record links nine similar brands, most of them in Biotechnology Research.
ABN52664963937
| ONCOPARSE PTY LTD | ABN 52664963937 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Oncoparse is striving to revolutionize the early detection and treatment monitoring of Pancreatic Cancer by developing a cutting-edge bioinformatics pipeline. This pipeline is set to dramatically increase the precision and efficacy of variant calling from non-invasive liquid biopsies.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Victoria entity on the ABR: ONCOPARSE PTY LTD (ABN 52 664 963 937), high confidence.
4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Melbourne 3000.
None linked to this brand.
11 profiles list Oncoparse as a peer — 88th percentile in Medical and Diagnostic Laboratories. It lists ten peers of its own. PharmSky Research and Southern Clinical Development Consulting list it back.